Medindia

X

BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales

Wednesday, November 7, 2007 General News J E 4
Advertisement
FREDERICK, Md., Nov. 6 BioElectronicsCorporation, (Pink Sheets: BIEL), announced today that Michael Seidenman, R.Ph. has joined the company's management as Vice President of Sales.

Mr. Seidenman is a licensed pharmacist, a surgical appliance technician,and is well versed in electro medicine devices. He brings to the companytwenty five years experience in medical device sales management. Mr.Seidenman has launched many new products, developed and managed independentsales agent organizations, established and managed wholesale distributors, andsold and established national accounts. As a consultant he has evaluated,established, and trained national sales forces.

"We are very pleased to have Mike join our management team. We know thathis extensive experience and knowledge base will be a driving force for thecompany's sales. We are sure that he will have an innovative approach tobroadening our current approach to marketing and selling the healing benefitsof ActiPatch," said Andrew Whelan, President of BioElectronics.

BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is adrug-free anti-inflammatory patch with an embedded battery operated microchipthat delivers weeks of continuous pulsed therapy for a few cents per hour.The unique ActiPatch delivery system, using patented technology, provides acost-effective, patient friendly method to reduce soft tissue pain andswelling.

For more information visit http://www.bioelectronicscorp.com

Safe Harbor Statement:

This news release contains forward-looking statements related to futuregrowth and earnings opportunities. Such statements are based upon certainassumptions and assessments made by management of both companies in light ofcurrent conditions, expected future developments and other factors it believesto be appropriate. Actual results may differ as a result of factors overwhich the companies have no control.

SOURCE BioElectronics Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Snapple's New Antioxidant Water and LYTeWater Take...
S
Osteotech Reports 2007 Third Quarter Financial Res...